Ebola: Korean Air suspends flights to Kenya

The world's worst outbreak of Ebola has claimed the lives of 1,069 people.

A doctor of the national public health institute controls the temperature of people at the airport, in Abidjan on 13 August 2014. Picture: AFP.

SEOUL - Korean Air Lines Co Ltd said on Thursday it will suspend flights to and from Nairobi from 20 August to prevent the spread of the deadly Ebola virus.

Korean Air said it had been operating three return flights from Incheon, South Korea, to the capital of Kenya a week.

The company said it would determine whether to resume the flights based on a change in conditions. It did not elaborate.

The world's worst outbreak of Ebola has claimed the lives of 1,069 people and there are 1,975 probable and suspected cases, the vast majority in Guinea, Liberia and Sierra Leone, according to new figures from the World Health Organisation (WHO).

Three people have died in Nigeria.


A consignment of experimental Ebola drugs arrived by plane in Liberia on Wednesday to treat two doctors suffering from the virus, which has killed more than 1,000 people across four West African countries.

The drug, ZMapp, arrived in two boxes on a commercial flight from the United States carried by Liberia's Minister of Foreign Affairs, Augustine Ngafuan, and was unloaded at the VIP terminal, a Reuters witness said.

It will be taken to a hospital in the capital and administered to Liberian doctors Zukunis Ireland and Abraham Borbor, who officials said contracted the disease while attending to patients, including a late colleague.

The UN health agency said only around 10 to 12 doses of the drug have been made and this raises difficult ethical questions about who should get priority access.

The doctors will be the first Africans to receive it, though it has been given to a Spanish priest who later died and two US aid workers who are reported to have shown signs of recovery.

Authorities are also concerned that ZMapp's unproven status could leave them open to the charge that humans are being used as guinea pigs.

"This is not the panacea to the problem. It is at the risk of the patient," Liberia's Assistant Health Minister Tolbert Nyenswah told journalists at Monrovia's main airport.

Information Minister Lewis Brown told Reuters the drug merely offered a "glimmer of hope" and its use was little more than a gamble.

Even so, the clamour for it is strong given that the contagious haemorrhagic disease is killing more than half of its victims and there is no known cure or vaccine.

"I welcome it. It is very good. Our nurses are dying. If you bring them the medication it will make them stronger to fight Ebola," said stationery seller James Liburd, in Monrovia.


In evidence of the ethical dilemma, Melvin Korkor, the first Liberian doctor to survive Ebola, said he would not have used ZMapp when he was fighting for his life because US authorities said they were not responsible for any adverse effects.

"Any drug that has not been approved by FDA should not be administered," he told Reuters.

One of the epidemic's most tragic consequences is the toll on health care workers who rushed in as first responders only to become infected themselves due to inadequate protection measures or diagnoses of patients that came too late or were inaccurate.

The WHO said this week that 170 health care workers had been infected and at least 81 had died.

Sierra Leonean doctor Modupeh Cole became the latest medical practitioner to die of Ebola, a health ministry spokesman said on Tuesday.

He contracted the disease after treating a patient who later proved to have the virus and died. The country's leading Ebola doctor, Shek Umar Khan, also died last month.

Eight Chinese health workers are in quarantine in Sierra Leone because they may have contracted Ebola, according to the spokesman for the Chinese embassy in Freetown, Xu Zhou.

The seven doctors and one nurse treated patients at two Chinese-run hospitals in Freetown who later died from Ebola. One of the doctors has emerged from quarantine after a 21-day observation period, Zhou told Reuters.